Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.07.18	Biotech Stocks Facing FDA Decision In August (RTTNews)
10.07.18	ISR Soars On FDA Nod For GammaTile, KMPH On Watch, Investors Believe In XLRN (RTTNews)
20.06.18	Sempra Energy Declares Common And Preferred Dividends (PR Newswire)
19.06.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX (PR Newswire)
19.06.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX (PR Newswire)
19.06.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX (PR Newswire)
19.06.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Valeant Pharmaceuticals International, Inc. (VRX) (PR Newswire)
19.06.18	CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today (RTTNews)
18.06.18	Valeant Suffers Psoriasis Setback (RTTNews)
18.06.18	Ortho Dermatologics Says FDA Issues CRL For DUOBRII Lotion (RTTNews)
18.06.18	FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion (PR Newswire)
18.06.18	FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion (PR Newswire)
16.06.18	An Ear To The Pharma: 5 Stocks To Watch (OBSV, GERN, SRPT…) (RTTNews)
14.06.18	Colibri Completes Drilling at Pilar, Receives Results of Soil Sample Program, and Receives Assay Results on Final 4 Holes on its Pitaya Property Joint Venture With Agnico Eagle (PR Newswire)
14.06.18	Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops (PR Newswire)
14.06.18	Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops (PR Newswire)
14.06.18	Interface Agrees to Acquire Nora Systems (PR Newswire)
12.06.18	Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins (PR Newswire)
12.06.18	Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins (PR Newswire)
09.06.18	An Ear To The Pharma: 8 Stocks To Watch (CMRX, CRBP, KPTI, VRX…) (RTTNews)
31.05.18	Salix To Highlight New Clinical Data During Digestive Disease Week (PR Newswire)
31.05.18	Salix To Highlight New Clinical Data During Digestive Disease Week (PR Newswire)
31.05.18	Post Premieres New Cereal Hits this Summer (PR Newswire)
29.05.18	Biotech Stocks Facing FDA Decision In June (RTTNews)
15.05.18	Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference (PR Newswire)
15.05.18	Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference (PR Newswire)
15.05.18	VRX Investor Alert: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors (PR Newswire)
10.05.18	Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference (PR Newswire)
10.05.18	Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference (PR Newswire)
10.05.18	Valeant To Seek Refinancing of its Existing Credit Agreement (PR Newswire)
10.05.18	Valeant To Seek Refinancing of its Existing Credit Agreement (PR Newswire)
08.05.18	Valeant Posts Q1 Loss; To Change Its Name To Bausch Health Companies (RTTNews)
08.05.18	Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance (PR Newswire)
08.05.18	Valeant Will Become Bausch Health Companies Inc. (PR Newswire)
08.05.18	Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance (PR Newswire)
08.05.18	Valeant Will Become Bausch Health Companies Inc. (PR Newswire)
07.05.18	Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine (PR Newswire)
07.05.18	Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine (PR Newswire)
07.05.18	Salix Pharma, Norgine Announce FDA Approval Of PLENVU - Quick Facts (RTTNews)
07.05.18	Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies (PR Newswire)
07.05.18	Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies (PR Newswire)
03.05.18	Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference (PR Newswire)
03.05.18	Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference (PR Newswire)
03.05.18	AKAO Slumps On FDA Panel Vote, ESPR Awaits Data In May, STAA Shines (RTTNews)
02.05.18	Bausch + Lomb ULTRA Contact Lenses Get FDA Approval For Extended Wear Indication (RTTNews)
02.05.18	Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication (PR Newswire)
02.05.18	Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication (PR Newswire)
02.05.18	Valeant Announces 2018 Annual Meeting Results (PR Newswire)
28.04.18	Biotech Stocks Facing FDA Decision In May (RTTNews)
27.04.18	Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Valeant Pharmaceuticals International Inc.

Aktien Top/Flop

Meistgelesene Nachrichten